Literature DB >> 8823246

Plasmodium falciparum: amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance.

A S Lim1, D Galatis, A F Cowman.   

Abstract

Amplification and overexpression of the pfmdr1 gene has been associated with mefloquine resistance in Plasmodium falciparum. We have selected for parasites more resistant to mefloquine from P. falciparum FAC8, a clone that has three copies of pfmdr1. The parasite lines derived from this selection were up to threefold more resistant to mefloquine. The mefloquine-selected parasites were also more resistant to quinine and halofantrine, suggesting a multidrug resistance phenotype. In contrast to previous findings, the selection of P. falciparum FAC8 on mefloquine did not alter the copy number or the level of expression of pfmdr1. Sequence analysis of pfmdr1 from the selected lines showed no change in the amino acids. These results show that alterations in pfmdr1 are not involved in mediating the increased mefloquine resistance observed in this clone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823246     DOI: 10.1006/expr.1996.0077

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

1.  Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.

Authors:  Denise P Mawili-Mboumba; Jürgen F J Kun; Bertrand Lell; Peter G Kremsner; Francine Ntoumi
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi.

Authors:  Pedro V L Cravo; Jane M-R Carlton; Paul Hunt; Laura Bisoni; Rose Ann Padua; David Walliker
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 3.  How can we identify parasite genes that underlie antimalarial drug resistance?

Authors:  Tim Anderson; Standwell Nkhoma; Andrea Ecker; David Fidock
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

4.  Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.

Authors:  Marina Chavchich; Lucia Gerena; Jennifer Peters; Nanhua Chen; Qin Cheng; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 5.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

6.  Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.

Authors:  Amar Bir Singh Sidhu; Anne-Catrin Uhlemann; Stephanie G Valderramos; Juan-Carlos Valderramos; Sanjeev Krishna; David A Fidock
Journal:  J Infect Dis       Date:  2006-07-11       Impact factor: 5.226

7.  Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

Authors:  Amy L Pickard; Chansuda Wongsrichanalai; Anne Purfield; Deborah Kamwendo; Kathryn Emery; Christy Zalewski; Fumihiko Kawamoto; R Scott Miller; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.

Authors:  Piyanuch Preechapornkul; Mallika Imwong; Kesinee Chotivanich; Wirichada Pongtavornpinyo; Arjen M Dondorp; Nicholas P J Day; Nicholas J White; Sasithon Pukrittayakamee
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

9.  The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.

Authors:  R N Price; C Cassar; A Brockman; M Duraisingh; M van Vugt; N J White; F Nosten; S Krishna
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

10.  Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil.

Authors:  Juliana Inoue; Dinora Lopes; Virgílio do Rosário; Marta Machado; Angélica D Hristov; Giselle Fmc Lima; Maria J Costa-Nascimento; Aluísio C Segurado; Silvia M Di Santi
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.